Treating multi drug resistant TB and HIV/AIDS in Manipur, India

Access to medicines

Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines.

During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in developed countries, remarkable progress was being made in the field of health. Two decades on, medicines in developing countries are still either too expensive, aren't suitable to be used in many of the contexts in which we work (for example, in hot, humid conditions or where there's a lack of electricity), or simply don't exist for the diseases we need to treat.

In 1999, we launched the Campaign for Access to Essential Medicines, now known as the Access Campaign. Its mission focuses on three areas: overcoming barriers to access to essential medicines, stimulating research and development for neglected diseases, and promoting health exceptions to global trade agreements. In 2003, MSF joined several research institutes, including the Institut Pasteur, to create the Drugs for Neglected Diseases initiative (DNDi), a non-profit research and development organisation engaged in research and development of new treatments for neglected diseases.

 
Website

MSF Access Campaign

msfaccess.org
 
MSF Intervention in Alcalá de Henares
Coronavirus disease COVID-19

MSF calls for no patents or profiteering on COVID-19 drugs and vaccines

Press Release 27 Mar 2020
 
Wishlist 2020 - FUTURE [Twitter version]
Access to medicines

Our 2020 wishlist - five New Year's resolutions for medical care

Campaign 22 Jan 2020
 
Pneumonia vaccine signs
Access to medicines

Gavi must ensure more children get new, more affordable pneumonia vaccine

Press Release 21 Jan 2020
 
Measles outbreak in Maiduguri
Nigeria

Medical assistance urgently needed outside northeast ‘garrison’ towns

Interview 19 Dec 2019
 
MSF stunt at Gavi replenishment meeting Berlin
Access to medicines

Pharma giants shouldn’t receive multi-million dollar pneumonia vaccine subsidy

Press Release 3 Dec 2019
 
2018 Union Conference - Johnson & Johnson (J&J) protest
Access to medicines

MSF protests at TB conference against drug corporations keeping lifesaving medicines from people

Press Release 30 Oct 2019
 
OLEG Story: "I’d been through many things in my life, but I’d never experienced anything like it.”
Tuberculosis

TB drug delamanid must be more affordable and made available in more countries

Statement 10 Oct 2019
 
Johnson & Johnson demonstration - bedaquiline
Access to medicines

MSF demands Johnson & Johnson reduce price of lifesaving TB drug

Press Release 10 Oct 2019
 
Insein clinic, for treatment for HIV, TB, and Hepatitis C in Yangon. By Alessandro Penso, Feb 2018.
HIV/AIDS

Urgent boost and reality check needed for HIV and TB funding

Press Release 6 Oct 2019
Up Next
30 August 2019